Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines, No. 009, October 2004
(2004; 6 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentWhy pharmacovigilance is needed
View the documentThe aims of pharmacovigilance
Close this folderPartners in pharmacovigilance
View the documentPharmacovigilance in national drug policy
View the documentPharmacovigilance in the regulation of medicines
View the documentPharmacovigilance in clinical practice
View the documentPharmacovigilance in disease control public health programmes
View the documentCommunicating the outcome of pharmacovigilance
View the documentWHO Programme for International Drug Monitoring
View the documentConclusion
View the documentKey documents
 

Pharmacovigilance in clinical practice

Safety monitoring of medicines in common use should be an integral part of clinical practice. The degree to which clinicians are informed about the principles of pharmacovigilance, and practise according to them, has a large impact on the quality of health care. Education and training of health professionals in medicine safety, exchange of information between national pharmacovigilance centres, the coordination of such exchange, and the linking of clinical experience of medicine safety with research and health policy, all serve to enhance effective patient care. A regular flow and exchange of information in this way means that national pharmacovigilance programmes are ideally placed to identify gaps in our understanding of medicine-induced diseases.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019